Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
JUBLPHARMA.NSthis companyJubilant Pharmova Limited	₹966.00	32.46×	1.82×	1.56×	12.07×	-242.1%	30.1%	9.9%	4.8%	5.6%	4.0%	-3.4%	0.51×	1.85×	3.87×	1.62×	0.6%	5	—	2	C
AJANTPHARM.NSAjanta Pharma Limited	₹3,344.00	33.18×	7.74×	6.43×	22.46×	64.5%	51.4%	24.3%	19.4%	23.3%	20.5%	0.4%	0.06×	0.1×	82.23×	2.64×	1.0%	5	18.51	4	A
ALIVUS.NSAlivus Life Sciences Limited	₹1,474.40	21.18×	3.59×	4.69×	14.44×	-46.0%	44.6%	28.3%	22.1%	16.9%	15.6%	2.2%	0.02×	0.07×	134.39×	5.21×	0.5%	—	—	4	A-
APLLTD.NSAlembic Pharmaceuticals Limited	₹1,017.30	19.32×	2.3×	1.77×	12.9×	3.1%	45.1%	10.9%	9.2%	11.9%	10.4%	2.0%	0.25×	1.11×	8.54×	1.76×	1.7%	4	—	2	B-
CAPLIPOINT.NSCaplin Point Laboratories Limited	₹2,502.50	17.84×	3.19×	5.23×	12.35×	56.5%	48.0%	31.5%	29.3%	17.9%	15.2%	2.9%	0×	-0.7×	790.9×	6.7×	0.4%	4	27.58	2	C
CIPLA.NSCipla Limited	₹1,403.80	25.49×	2.87×	3.51×	15.19×	112.4%	42.7%	16.7%	13.8%	11.3%	9.8%	2.6%	0.02×	-0.06×	86.67×	3.44×	1.3%	4	9.92	4	A-
Peer median	—	21.18×	3.19×	4.69×	14.44×	56.5%	45.1%	24.3%	19.4%	16.9%	15.2%	2.2%	0.02×	0.07×	86.67×	3.44×	1.0%	4	18.51	4	—